- Home
- A-Z Publications
- Current Medicinal Chemistry
- Previous Issues
- Volume 28, Issue 25, 2021
Current Medicinal Chemistry - Volume 28, Issue 25, 2021
Volume 28, Issue 25, 2021
-
-
Roles of Interferon Induced Protein with Tetratricopeptide Repeats (IFIT) Family in Cancer
Authors: Xing F. Tan, Qifan Chen, San Hue Hua and George Wai YipThe Interferon-induced protein with tetratricopeptide repeats (IFIT) family is an important component of the antiviral immune response. There are currently four known IFIT family members in humans, namely IFIT1, IFIT2, IFIT3 and IFIT5. Recent discoveries have brought attention to the significant roles of IFITs in cancer. This review summarises current knowledge on the biological roles of different IFIT proteins in various t Read More
-
-
-
Role of C1QBP/p32 and its Therapeutic Potential in Breast Carcinoma and other Cancers
Authors: Ken Matsumoto and Boon-Huat BayThe complement component 1, q subcomponent binding protein (C1QBP/gC1q-R/p32/HABP1/TAP/YBAP1), is a ubiquitous, multifunctional protein. C1QBP localizes mainly to mitochondria due to its N-terminal mitochondrial localization signal, but it can also be found in different subcellular compartments including the cell surface, nucleus, cytoplasm, and extracellular space. C1QBP has been reported to interact with a variet Read More
-
-
-
Syndecan-1 (CD138) as a Pathogenesis Factor and Therapeutic Target in Breast Cancer
Authors: Mona Sheta and Martin GötteThe successive stages of breast cancer growth and dissemination depend on cell-autonomous factors and the communication between tumor cells and their surrounding cellular and extracellular matrix microenvironment. The cell surface heparan sulfate proteoglycan Syndecan-1 is dysregulated both in tumor cells and cells of the breast tumor stroma, indicating a potential role in the pathogenesis of this most freque Read More
-
-
-
Dysregulation of HOX as a Potential Therapeutic Target in Breast Cancer
Authors: Ji-Yeon Lee and Myoung H. KimHOX genes belong to the highly conserved homeobox superfamily, responsible for the regulation of various cellular processes that control cell homeostasis, from embryogenesis to carcinogenesis. The abnormal expression of HOX genes is observed in various cancers, including breast cancer, where they act as oncogenes or as suppressors of cancer, according to context. In this review, we analyze HOX gene expression Read More
-
-
-
Nuclear Long Non-Coding RNAs as Epigenetic Regulators in Cancer
Authors: Hiroaki Tachiwana and Noriko SaitohBackground: Transcriptome analyses have revealed the presence of numerous long non-coding RNAs (lncRNAs) in mammalian cells. Many lncRNAs are expressed in development-, differentiation-, and disease-specific manners, suggesting their importance as cell regulators. Some nuclear lncRNAs are bound to specific genomic loci, either near or distant from their own transcription sites, and regulate gene expression in cis Read More
-
-
-
The Potential Use of RNA-based Therapeutics for Breast Cancer Treatment
Authors: Yangyang Song, Xinyu Ke and Leilei ChenBreast cancer is one of the most lethal cancers in women worldwide, and the development of efficient treatments faces several challenges. Breast cancer is characterized by histological and functional heterogeneity in aspects such as tumorigenesis, metastasis, and drug resistance. RNA therapy has emerged as a highly attractive class of drugs for the treatment and prevention of breast cancer. It might play remarkable r Read More
-
-
-
Targeting the JAK/STAT Signaling Pathway for Breast Cancer
Authors: Fei Shao, Xiaonan Pang and Gyeong H. BaegBreast cancer is the most common malignant tumor in women worldwide. Traditional ways of treatment, including radiotherapy and endocrine therapy, for breast cancer have inevitable side effects. In recent decades, targeted therapies for breast cancer have rapidly advanced and shown a promising future. The JAK/STAT signaling pathway has been shown to play important roles in tumorigenesis, maintenance and metastasi Read More
-
-
-
Therapeutic Potential of Lymphoid Infiltrates in Breast Cancer
Authors: Xiao-Yang Chen and Puay H. TanDespite diagnostic and therapeutic advances in breast cancer, it remains the most frequently diagnosed malignancy in females, with the highest cancer-related mortality rate in women globally. With an improved understanding of the complex interactions between breast cancer and the immune system, immunotherapy has shown great potential in clinical management, potentially adding to current treatment modalities. Read More
-
-
-
High-Intensity Focused Ultrasound in the Treatment of Breast Cancer
Authors: Loreto B. Feril, Rodney L. Fernan and Katsuro TachibanaHigh-intensity focused ultrasound (HIFU) is a non-invasive method of ablating malignant tumors. This paper will review the current clinical application of HIFU specially in the treatment of breast cancer. In addition to clinical studies, this review will also look into some basic studies that could address the technical issues related to this modality. In general, HIFU is considered to be safe being non-invasive and non-ionizing. Read More
-
-
-
The Anti-osteoporosis Effects of Natto on Bone Mineral Density in Perimenopausal Women
Authors: Yuan Liu, Yuan He, Baorong He and Lingbo KongObjective and Aims: This study aims to conduct a systematic review and meta-analysis for prospective studies to investigate the improvement effects of natto on bone mineral density (BMD) in perimenopausal women. Methods: PubMed, EMBASE and Cochrane database searched upto February 2019. This study was carried out according to the PRISMA guidelines10 for systematic reviews. The protocol of the review was Read More
-
-
-
Current Study of Medicinal Chemistry for Treating Spinal Tuberculosis
Authors: Biao Wang, Yuhang Wang and Dingjun HaoTuberculosis, caused by Mycobacterium tuberculosis, is one of the oldest diseases in the world and is one of the top ten causes of death in the world, ranking first mortality in infectious diseases, far beyond the frightening disease AIDS. Besides that, spinal tuberculosis is the most common form of extrapulmonary tuberculosis, accounting for approximately 1 to 3% of all tuberculosis cases, and accounting for 50% of muscul Read More
-
-
-
Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
Authors: Haibao Zhang and Guodong ZhuRenal cell carcinoma (RCC) is one of the most lethal urologic malignancies. Partial or radical nephrectomy is the major surgical management for localized RCC, however, almost 30% of patients will develop recurrence and metastasis after surgery. Metastatic RCC (mRCC) is a disease with a very poor prognosis, and the 5-year survival of the mRCC is commonly less than 10%. Unfortunately, mRCC is highly resistant to chemo Read More
-
-
-
The Role of Probiotics and Prebiotics in Osteolastogenesis and Immune Relevance
Authors: Datong Li, Yuan Liu, Xiaobin Yang and Lingbo KongOsteoporosis is very common in middle-aged and elderly people, and its main feature is a disease characterized by bone mass reduction and bone microstructure changes, accompanied by a corresponding increase in the risk of fracture. This is a disease affected by many factors and is more common in postmenopausal women. Currently, the treatment of osteoporosis is mainly to prevent bone resorption and reduce the risk Read More
-
Volumes & issues
-
Volume 32 (2025)
-
Volume 31 (2024)
-
Volume 30 (2023)
-
Volume 29 (2022)
-
Volume 28 (2021)
- Issue 42
- Issue 41
- Issue 40
- Issue 39
- Issue 38
- Issue 37
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 18
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 27 (2020)
-
Volume 26 (2019)
-
Volume 25 (2018)
-
Volume 24 (2017)
-
Volume 23 (2016)
-
Volume 22 (2015)
-
Volume 21 (2014)
-
Volume 20 (2013)
-
Volume 19 (2012)
-
Volume 18 (2011)
-
Volume 17 (2010)
-
Volume 16 (2009)
-
Volume 15 (2008)
-
Volume 14 (2007)
-
Volume 13 (2006)
-
Volume 12 (2005)
-
Volume 11 (2004)
-
Volume 10 (2003)
-
Volume 9 (2002)
-
Volume 8 (2001)
-
Volume 7 (2000)
Most Read This Month
Article
content/journals/cmc
Journal
10
5
false
en
